{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:12:12Z","timestamp":1794874332540,"version":"4.9.1"},"reference-count":107,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2026,8,3]]},"DOI":"10.1080\/17425247.2026.2688990","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T10:30:55Z","timestamp":1781433055000},"page":"1495-1509","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Current trends in semaglutide therapy and strategies to improve its bioavailability"],"prefix":"10.1080","volume":"23","author":[{"given":"Swasthik","family":"Nayak","sequence":"first","affiliation":[{"name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education","place":["Manipal, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha D.","family":"Dessai","sequence":"additional","affiliation":[{"name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education","place":["Manipal, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-3114","authenticated-orcid":false,"given":"Usha Y.","family":"Nayak","sequence":"additional","affiliation":[{"name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education","place":["Manipal, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-S067"},{"key":"e_1_3_5_4_1","unstructured":"Kumar R Saha P Kumar Y et al. A review on diabetes mellitus: Type1 & Type2."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002122"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53480-4.00015-1"},{"key":"e_1_3_5_7_1","unstructured":"Type 1 diabetes mellitus | nature reviews disease primers [Internet]. [cited 2025 Jun 19]. Available from: https:\/\/www.nature.com\/articles\/nrdp201716"},{"key":"e_1_3_5_8_1","unstructured":"Type 2 diabetes mellitus | nature reviews disease primers [Internet]. [cited 2025 Jun 19]. Available from: https:\/\/www.nature.com\/articles\/nrdp201519"},{"key":"e_1_3_5_9_1","unstructured":"Genetics of diabetes mellitus and diabetes complications | nature reviews nephrology. [cited 2025 May 16]. Available from: https:\/\/www.nature.com\/articles\/s41581-020-0278-5"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S67400"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.04.012"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031882"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2025.01.021"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0306273"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110708"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90327-4"},{"key":"e_1_3_5_18_1","unstructured":"Metformin reduces liver glucose production by inhibition of fructose-1\u20136-bisphosphatase | nature medicine [Internet]. [cited 2025 Jun 10]. Available from:https:\/\/www.nature.com\/articles\/s41591-018-0159-7"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/806979"},{"key":"e_1_3_5_20_1","unstructured":"Akmal M Patel P Wadhwa R. Alpha glucosidase inhibitors. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 10]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557848\/ PubMed PMID: 32496728."},{"key":"e_1_3_5_21_1","unstructured":"Padda IS Mahtani AU Parmar M. Sodium-glucose transport protein 2 (SGLT2) inhibitors. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jun 10]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576405\/ PubMed PMID: 35015430."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14043"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002"},{"key":"e_1_3_5_25_1","volume-title":"StatPearls [Internet]","author":"Latif W","year":"2026","unstructured":"Latif W, Lambrinos KJ, Patel P, et al. Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 [cited 2025 Jun 11]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572151\/ PubMed PMID: 34283517."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm500810s"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-022-03265-3"},{"key":"e_1_3_5_28_1","unstructured":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | signal transduction and targeted therapy [Internet]. [cited 2025 Jun 10]. Available from: https:\/\/www.nature.com\/articles\/s41392-024-01931-z"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2022.170749"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.721135"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11195-6"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.140"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01499-w"},{"key":"e_1_3_5_34_1","volume-title":"In: StatPearls [Internet]","author":"Kommu S","year":"2026","unstructured":"Kommu S, Whitfield P. Semaglutide [updated 2024 Feb 11]. In: In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan- [cited 2025 May 4]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK603723\/ PubMed PMID: 38753931."},{"key":"e_1_3_5_35_1","unstructured":"Semaglutide. Wikipedia [Internet]. 2025 [cited 2025 May 3]. Available from: https:\/\/en.wikipedia.org\/w\/index.php?title=Semaglutide&oldid=1284569793"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00155"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17101313"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-025-01534-4"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2023.08.010"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01623-w"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11030433"},{"key":"e_1_3_5_42_1","unstructured":"The cardiovascular effects of GLP-1 receptor agonists - okerson - 2012 - cardiovascular therapeutics - wiley online library [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/j.1755-5922.2010.00256.x"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-022-03302-1"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2019.107520"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13899"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1090295"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.140"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00951-6"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0668-z"},{"key":"e_1_3_5_51_1","unstructured":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial | nature medicine [Internet]. [cited 2025 Jun 12]. Available from: https:\/\/www.nature.com\/articles\/s41591-024-02996-7"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46120872"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1398059"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2024.100340"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108906"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.09.054"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.2337\/cd22-0118"},{"key":"e_1_3_5_58_1","unstructured":"Full article: clinical pharmacokinetics of semaglutide: a systematic review [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.2147\/DDDT.S470826"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00576"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-021-00341-8"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.645617"},{"key":"e_1_3_5_62_1","doi-asserted-by":"crossref","unstructured":"Oral semaglutide | clinical diabetes | American diabetes Association [Internet]. [cited 2025 Jun 12]. Available from: https:\/\/diabetesjournals.org\/clinical\/article\/38\/1\/109\/32187\/Oral-Semaglutide","DOI":"10.2337\/cd19-0079"},{"key":"e_1_3_5_63_1","unstructured":"A review of GLP-1 receptor agonists in type 2 diabetes: a focus on the mechanism of action of once-weekly agents - Cornell - 2020 - journal of clinical pharmacy and therapeutics - wiley online library [Internet]. [cited 2025 Jun 19]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/jcpt.13230"},{"key":"e_1_3_5_64_1","unstructured":"Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery | drug delivery and translational research [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/link.springer.com\/article\/10.1007\/s13346-021-01000-w"},{"key":"e_1_3_5_65_1","unstructured":"novoMEDLINK [Internet]. Novo Nordisk medicines containing semaglutide | semaglutide.com. [cited 2025 May 16]. Available from https:\/\/www.novomedlink.com\/semaglutide\/medicines.html"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.04.001"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09735-8"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01025-x"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01078-y"},{"key":"e_1_3_5_70_1","unstructured":"Transmucosal absorption enhancers in the drug delivery Field - google books [Internet]. [cited 2025 Jun 20]. Available from: https:\/\/books.google.co.in\/books?hl=en&lr=&id=DlrIDwAAQBAJ&oi=fnd&pg=PA65&dq=eudragit+s+100+coating+of+semaglutide+aminocaprylate&ots=b99xOzYekA&sig=GBDAB3zO5UdmVc2kzhAzrg_XeMA&redir_esc=y#v=onepage&q&f=false"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/adb2cf"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16070886"},{"key":"e_1_3_5_73_1","unstructured":"Sauerberg P Bjerregaard S Nielsen FS. Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid [Internet]. US11382957B2. 2022 [cited 2025 May 25]. Available from: https:\/\/patents.google.com\/patent\/US11382957B2\/en?q=(semaglutide)&oq=semaglutide"},{"key":"e_1_3_5_74_1","unstructured":"SNAC for enhanced oral bioavailability: an updated review | Pharmaceutical research [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/link.springer.com\/article\/10.1007\/s11095-022-03459-9"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/02652048.2021.1889059"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106793"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123991"},{"key":"e_1_3_5_78_1","unstructured":"Microspheres for controlled release drug delivery: expert opinion on biological therapy: vol 4 No 1 [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1517\/14712598.4.1.35"},{"key":"e_1_3_5_79_1","unstructured":"Microspheres for drug delivery | SpringerLink [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/link.springer.com\/chapter\/10.1007\/978-0-387-25842-3_2"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44174-025-00281-w"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-022-00584-w"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040480"},{"key":"e_1_3_5_83_1","unstructured":"Nanoparticles - a review | tropical journal of Pharmaceutical research [Internet]. [cited 2025 Jul 27]. Available from: https:\/\/www.ajol.info\/index.php\/tjpr\/article\/view\/14634"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124669"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.1023"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113925"},{"issue":"6","key":"e_1_3_5_87_1","first-page":"05","article-title":"A review on recent advances of enteric coating","volume":"2","author":"Hussan SD","year":"2012","unstructured":"Hussan SD, Santanu R, Verma P, et al. A review on recent advances of enteric coating. IOSR J Pharm. 2012;2(6):05\u201311.","journal-title":"IOSR J Pharm"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780203908563"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.35629\/4494-100212241232"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00662-x"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020587"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2016.05.010"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.12.029"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.4103\/2231-4040.107498"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.645563"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01594-7"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2025.129"},{"key":"e_1_3_5_98_1","unstructured":"Novo Nordisk A\/S. A comparative bioavailability trial of steady state semaglutide exposure with the Current formulation (semaglutide) and a New formulation (semaglutide C) of oral semaglutide in healthy subjects [clinical trial registration] [Internet]. Clinical trial registration NCT04109508. clinicaltrials.gov; 2021. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04109508"},{"key":"e_1_3_5_99_1","unstructured":"Novo Nordisk A\/S. A comparative bioavailability trial of steady state semaglutide exposure with the Current formulation (semaglutide) and a new formulation (semaglutide D) of oral semaglutide in healthy subjects [clinical trial registration] [Internet]. Clinical trial registration NCT04097600. clinicaltrials.gov; 2022. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04097600"},{"key":"e_1_3_5_100_1","unstructured":"Veru Inc. A Phase 2 dose-finding and proof-of-concept study to evaluate the Effect on body composition and safety of enobosarm in patients treated with glucagon-like peptide-1 (GLP-1) receptor agonists for chronic weight management [clinical trial registration] [Internet]. Clinical trial registration NCT06282458. clinicaltrials.gov; 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06282458"},{"key":"e_1_3_5_101_1","unstructured":"Castorino K. Comparison of oral semaglutide with matched oral semaglutide placebo as an early treatment for latino adults with type 2 diabetes receiving enhanced lifestyle care [clinical trial registration] [Internet]. Clinical trial registration NCT04938388. clinicaltrials.gov; 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04938388"},{"key":"e_1_3_5_102_1","unstructured":"Novo Nordisk A\/S. A randomised trial investigating steady state semaglutide exposure of 25 and 50 mg of oral semaglutide in different formulations in healthy subjects [clinical trial registration] [Internet]. Clinical trial registration NCT04524832. clinicaltrials.gov; 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04524832"},{"key":"e_1_3_5_103_1","unstructured":"Novo Nordisk A\/S. A multi-centre prospective non-interventional single-arm study investigating clinical parameters associated with the use of once-daily oral semaglutide in a real-world adult population with type 2 diabetes in Italy [clinical trial registration] [Internet]. Clinical trial registration NCT05230615. clinicaltrials.gov; 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05230615"},{"key":"e_1_3_5_104_1","unstructured":"Garibay PW Spetzler J Linderoth L et al. Double-acylated GLP-1 derivatives [Internet]. US9556250B2. 2017 [cited 2025 May 24]. Available from: https:\/\/patents.google.com\/patent\/US9556250B2\/en?q=(semaglutide)&oq=semaglutide"},{"key":"e_1_3_5_105_1","unstructured":"Jensen CB Kristensen P Rasmussen MF et al. Use of long-acting GLP-1 peptides [Internet]. AU2018202504B2. 2020 [cited 2025 May 24]. Available from: https:\/\/patents.google.com\/patent\/AU2018202504B2\/en?q=(semaglutide)&oq=semaglutide"},{"key":"e_1_3_5_106_1","unstructured":"Vilhelmsen T Eliasen H Hansen T. Compositions of GLP-1 peptides and preparation thereof [Internet]. US11759503B2. 2023. Available from: https:\/\/patents.google.com\/patent\/US11759503B2\/en?q=(semaglutide)&oq=semaglutide"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307563"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156463"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2688990","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17425247.2026.2688990","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2688990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:34:24Z","timestamp":1785580464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2026.2688990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":107,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"alternative-id":["10.1080\/17425247.2026.2688990"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2026.2688990","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}